A seguir

Reprodução automática

Future antibody avenues for cutaneous lymphoma treatment

3 Visualizações • 08/09/23
Compartilhar
Embutir
administrator
administrator
Assinantes
0

Speaking from the European Organisation for the Research and Treatment of Cancer (EORTC) Cutaneous Lymphoma Task Force (CLTF) 2018 Congress, held in St. Gallen, Switzerland, Pietro Quaglino, MD, of the University of Turin, Turin, Italy, gives his insight into the novel therapies being explored for cutaneous T-cell lymphomas, including bretuximab vedotin and mogamulizumab .

Mostre mais
0 Comentários sort Ordenar por
Comentários do Facebook

A seguir

Reprodução automática